MX9705592A - Liposomes containing a corticosteroid. - Google Patents

Liposomes containing a corticosteroid.

Info

Publication number
MX9705592A
MX9705592A MX9705592A MX9705592A MX9705592A MX 9705592 A MX9705592 A MX 9705592A MX 9705592 A MX9705592 A MX 9705592A MX 9705592 A MX9705592 A MX 9705592A MX 9705592 A MX9705592 A MX 9705592A
Authority
MX
Mexico
Prior art keywords
corticosteroid
liposomes containing
liposomes
contained
compound
Prior art date
Application number
MX9705592A
Other languages
Spanish (es)
Other versions
MXPA97005592A (en
Inventor
Peter William Taylor
Janet Catherine Maas
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX9705592A publication Critical patent/MX9705592A/en
Publication of MXPA97005592A publication Critical patent/MXPA97005592A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A pharmaceutical composition comprising, as active ingredient, a compound of formula (I) contained in liposomes or dehydrated liposomes.
MXPA/A/1997/005592A 1995-01-24 1997-07-23 Pharmaceutical compositions containing corticosteroids and preparation of mys MXPA97005592A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9501286.0A GB9501286D0 (en) 1995-01-24 1995-01-24 Pharmaceutical compositions and preparations thereof
GB9501286.0 1995-01-24
PCT/GB1996/000083 WO1996022764A1 (en) 1995-01-24 1996-01-17 Liposomes containing a corticosteroid

Publications (2)

Publication Number Publication Date
MX9705592A true MX9705592A (en) 1997-11-29
MXPA97005592A MXPA97005592A (en) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
JPH10512876A (en) 1998-12-08
FI973049A0 (en) 1997-07-18
EP0859598A1 (en) 1998-08-26
CN1169115A (en) 1997-12-31
WO1996022764A1 (en) 1996-08-01
FI973049A (en) 1997-07-18
CZ234297A3 (en) 1997-10-15
NO973401L (en) 1997-07-23
GB9501286D0 (en) 1995-03-15
CA2210482A1 (en) 1996-08-01
NO973401D0 (en) 1997-07-23
AU4396196A (en) 1996-08-14

Similar Documents

Publication Publication Date Title
MY115339A (en) Compositions containing micronized nebivolol
AU5945396A (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
AU7547196A (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
AU5669398A (en) Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them
EP0727217A3 (en) Pharmaceutical composition containing god-type ellagitannin as active ingredient
AU6818196A (en) Substituted 2,4-imidazolidinedione compounds as pharmaceutical active ingredients
HUP9900753A3 (en) Chromone and coumarine derivatives, use thereof and fungicide compositions containing these compounds as active ingredients
GEP20002211B (en) Taxoids, Preparation Thereof, Pharmaceutical Compositions Containing Same
HUP9802822A3 (en) Halobenzimidazol derivatives, intermediates, preparation thereof and microbocide compositions containing these compounds as active ingredients
YU57600A (en) Bicyclic hydroxamic acid derivatives
HUP9900617A3 (en) Novel indole-, indoline- or tetrahydrokinoline derivatives as acat and lipid peroxidation inhibitors, use thereof, pharmaceutical compositions containing these compounds
CA2238553A1 (en) Cholesterol-lowering composition
ATE158504T1 (en) EFFORTABLE MIXTURES CONTAINING IBUPROFEN AND METHODS
ZA961138B (en) Solid active ingredient compositions containing hydroxypropylcellulose.
IL139318A (en) Sugar alcohol mixtures as therapeutic agents and pharmaceutical compositions containing the same
MX9708394A (en) Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation.
AU7498494A (en) New bis-naphthalimides for the treatment of cancer
AU7270798A (en) Antithrombotic agents
GEP19991872B (en) Novel Taxoids, Preparations Thereof, and Pharmaceutical Compositions Containing Same
UA48958C2 (en) 9-0-oxime derivatives of erythromycine and pharmaceutical composition thereof
NO973401L (en) Corticosteroid-containing compositions and their preparation
AU3580995A (en) Derivatives of carbohydrates and compositions containing them
MX9709453A (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form.
AU7470098A (en) Antithrombotic agents
MY115795A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them